NCT00911911View on ClinicalTrials.gov

Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

July 31, 2009

Conditions
Breast Cancer
Interventions
PROCEDURE

Blood sampling

Taken at different times : inclusion, at the cycle 4 and at the cycle 6 during the neoadjuvant chemotherapy

PROCEDURE

BIOPSY

Biopsy at the moment of inclusion, before neoadjuvant chemotherapy

PROCEDURE

SURGERY

Surgery after neoadjuvant chemotherapy

Trial Locations (5)

59020

Centre Oscar Lambret, Lille

Hopital Saint Vincent, Lille

76038

Centre Henri Becquerel, Rouen

74 107

Intercommunal Hospital, Annemasse

74 203

Geroges PIANTA Hospital, Thonon-les-Bains

All Listed Sponsors
lead

Centre Oscar Lambret

OTHER

NCT00911911 - Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy | Biotech Hunter | Biotech Hunter